Clinical Trials Browser

Has results × Pemetrexed × Breast × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT02983045 2023-03-13

PIVOT-02

BreastDermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02624700 2020-07-14

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Phase 2 Terminated

13 enrolled 13 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01803282 2020-06-02

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

Phase 1 Completed

236 enrolled 21 charts

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00470548 2018-01-10

Abraxane and Alimta in Advanced Solid Tumors

Phase 1/2 Terminated

49 enrolled 10 charts

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Breast Neoplasms, Male

NCT00149214 2012-03-21

Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

Phase 2 Completed

257 enrolled 15 charts

Breast

Breast Neoplasms

NCT00325234 2011-05-20

Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer

Phase 2 Completed

135 enrolled 19 charts

Breast

Breast Neoplasms

NCT00190671 2009-11-20

A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients

Phase 1/2 Completed

103 enrolled 19 charts

Breast

Breast Neoplasms

NCT00106002 2009-06-01

Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer

Phase 2 Completed

37 enrolled 9 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Carcinoma, Ductal

NCT00063570 2009-05-29

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Phase 2 Completed

73 enrolled 15 charts

Breast

Breast Neoplasms

Clinical Trials

MK-5890-001

PIVOT-02

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

Abraxane and Alimta in Advanced Solid Tumors

Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer

A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients

Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy